New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor.
Tomo IshidaTsuyoshi TakahashiToshirou NishidaHiromitsu OhnishiTakahiro TsuboyamaShinsuke SatoYujiro NakaharaYasuhiro MiyazakiAtsushi TakenoYukinori KurokawaTakuro SaitoKotaro YamashitaKoji TanakaKazuyoshi YamamotoTomoki MakinoMakoto YamasakiMasaaki MotooriYutaka KimuraKiyokazu NakajimaHidetoshi EguchiYuichiro DokiPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
The evaluation criteria based on EMC could be a sensitive method to predict the clinical outcome of imatinib treatment for patients with unresectable GIST.